Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine...
No comments:
Post a Comment